Physician profile
Conner Schmitz
NPI 1265168546
$1,204.55
in general payments reported to CMS, 2019-2025
19 companies · $645 in 2025
The $645 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.88 · 2023: $479 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.82 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.55 | 2023 | |
| Pfizer INC. | $234.98 | 2023-2025 | |
| Novo Nordisk INC | $111.25 | 2023-2025 | Ozempic, Wegovy |
| Amgen INC. | $110.28 | 2025 | Otezla, Repatha, Evenity |
| Biohaven Pharmaceutical Holding Company LTD. | $65.23 | 2022 | |
| Lilly USA, LLC | $62.57 | 2025 | Zepbound, Mounjaro, Kisunla |
| Takeda Pharmaceuticals U.S.A., INC. | $56.76 | 2022-2023 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.24 | 2025 | Jardiance |
| Boston Scientific Corporation | $46.35 | 2023 | Watchman Access System |
| Glaxosmithkline, LLC. | $36.97 | 2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $31.87 | 2025 | Farxiga |
| Ardelyx, INC. | $19.23 | 2025 | Ibsrela |
| Edwards Lifesciences Corporation | $17.81 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Seqirus USA INC | $17.09 | 2025 | Flucelvax, Fluad |
| Abbott Laboratories | $17.05 | 2025 | Freestyle Libre 3 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $14.39 | 2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $14.36 | 2025 | |
| Medtronic, INC. | $13.32 | 2023 | Closurefast |
| Cequr Corporation | $12.25 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conner Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.